Eisai: Animation Featuring Lymphatic Filariasis Elimination Activities Receives Animation Award at International Society for Neglected Tropical Diseases Festival 2021
Fujitsu Embarks on Partnership with Siemens Digital Industries Software Strengthening Global Competitiveness and Accelerating DX to Realize Smart, Sustainable Manufacturing
Lexus to Display LF-Z Electrified Concept and New ES
HKTDC International Sourcing Show: Fashion industry experts reveal post-pandemic moves
How China’s Poverty Eradication Work Contributes to the World
ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid…
TH1902 anti-tumor post-treatment effect persists longer than with docetaxel alone MONTREAL, April 10, 2021 (GLOBE…
CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
7 objective responses observed to date in multiple tumor types New responses reported in patients…
CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
— Late-breaking presentation highlights preclinical data for AO-176 in T-ALL — BRISBANE, Calif., April 10,…
Preliminary data demonstrate a robust increase in HPV16+-specific T cells, including up to 8% of…
VIP236 shows enhanced tumor targeting with robust antitumor activity across multiple xenograft models First-in-human studies…
-Translational analysis of patients that do not respond to PD-(L)1 inhibitors show high pretreatment intratumoral…
Collaboration with Precision for Medicine to develop novel flow cytometry PD-1 expression assay as a…